Clinical Trials Sponsored by Vigonvita Life Sciences

Total 831 results

Vigonvita Life Sciences

Not yet recruiting

Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Erectile Dysfunction

China
Vigonvita Life Sciences

Recruiting

Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules

Healthy Subjects

China
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Schizophrenia

China
Vigonvita Life Sciences

Completed

Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers

Healthy Subjects

China
Vigonvita Life Sciences

Completed

Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers

Healthy Subjects

China
Vigonvita Life Sciences

Recruiting

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Respiratory Syncytial Virus Infection

China
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Healthy Subjects

China
Vigonvita Life Sciences

Completed

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension

Healthy Subjects

China
Vigonvita Life Sciences

Completed

Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers

Healthy Subjects

China
Vigonvita Life Sciences

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

Respiratory Syncytial Virus Infections

China
Vigonvita Life Sciences

Completed

Drug-Drug Interaction (DDI) Study for TPN171H

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Effect of TPN171H on Spermatogenesis

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

COVID-19

China
Vigonvita Life Sciences

Completed

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

Erectile Dysfunction | Alcohol | Phosphodiesterase Inhibitor

China
Vigonvita Life Sciences

Completed

Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers

Healthy Subjects

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Recruiting

a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects

Erectile Dysfunction | Pulmonary Arterial Hypertension

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction

Erectile Dysfunction

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Erectile Dysfunction | Pulmonary Arterial Hypertension

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

Healthy Male Subjects

China
Nimble Science Ltd.
IGY Life Sciences

Recruiting

Evaluation of the Microbiome in Multiple Sclerosis

Multiple Sclerosis

Canada
Halucenex Life Sciences Inc.
KGK Science Inc.

Active, not recruiting

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

Post Traumatic Stress Disorder | Treatment Resistant Disorders

Canada
SK Life Science, Inc.
PRA Health Sciences

Completed

Bioavailability and Food Effect Study of 3 Types of Carisbamate

Healthy Subjects

United States
Recognify Life Sciences

Recruiting

A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

Schizophrenia | Cognitive Impairment | Cognitive Impairment Associated With Schizophrenia (CIAS)

United States
Achieve Life Sciences

Completed

A Study of Cytisinicline for Vaping Cessation in Adult Smokers (ORCA-V1)

Vaping | E-Cig Use

United States
Achieve Life Sciences

Completed

Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers

Smoking Cessation

Portugal
Rediscovery Life Sciences

Active, not recruiting

Study of Suramin in Subjects With Furosemide-Resistant AKI

Acute Kidney Injury

United States
Achieve Life Sciences

Completed

A Study of Cytisinicline for Smoking Cessation in Adult Smokers (ORCA-2)

Smoking Cessation

United States
Cymra Life Sciences

Completed

A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain (CYDEPS)

Pain | Back Pain | Chronic Pain | Neck Pain | Pain, Chronic | CBD | Pain, Back | Pain, Neck | THC

Australia
Recognify Life Sciences

Completed

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

Schizophrenia | Cognitive Impairment

United States
Wako Life Sciences

Unknown

A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers

Cirrhosis | Chronic Liver Diseases

Canada
LG Life Sciences

Completed

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Prader-Willi Syndrome

Korea, Republic of
LG Life Sciences

Completed

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s

Correction of Nasolabial Folds
LG Life Sciences

Completed

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s

Correction of Nasolabial Folds

China
LG Life Sciences

Completed

An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

Type 2 Diabetes Mellitus

Korea, Republic of
LG Life Sciences

Completed

Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Growth Hormone Deficiency | Chronic Renal Failure | Turner Syndrome | Infant, Small for Gestational Age | Short Stature, Idiopathic

Korea, Republic of
LG Life Sciences

Completed

Study of LC23-1306 in Healthy Male Subjects

Acute Coronary Syndrome

Korea, Republic of
LG Life Sciences

Completed

A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Rheumatoid Arthritis

Korea, Republic of
LG Life Sciences

Completed

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Type 2 Diabetes Mellitus
Transparency Life Sciences

Unknown

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States
Genzum Life Sciences

Completed

BE Study of Naftifine HCL

Tinea Pedis

United States, Dominican Republic
LG Life Sciences

Completed

Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Type 2 Diabetes | Dyslipidemia

Korea, Republic of
LG Life Sciences

Unknown

Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

ST-segment Elevation Myocardial Infarction

Korea, Republic of
LG Life Sciences

Completed

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

ST-segment Elevation Myocardial Infarction

Korea, Republic of
LG Life Sciences

Unknown

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Orthostatic Hypertension | Lower Leg Edema

Korea, Republic of
Integrity Life Sciences

Completed

Assessment of Activities of Daily Living in Adults With Chronic Low Back Pain Using a Nonoperative Treatment Modality

Low Back Pain

3

Subscribe